Lv51
890 积分 2022-09-14 加入
Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
1个月前
已完结
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
2个月前
已完结
Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse
4个月前
已完结
Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment
4个月前
已完结
Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity
4个月前
已完结
Design, Synthesis, and Optimization of Novel PD-L1 Inhibitors and the Identification of a Highly Potent and Orally Bioavailable PD-L1 Inhibitor
4个月前
已完结
Interfering with the Tumor–Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors
4个月前
已完结
Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
4个月前
已完结
Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
4个月前
已完结
Discovery of [1,2,4]Triazolo[4,3-a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
4个月前
已完结
皖公网安备34019202002308
